In order to determine the molecular differences between ERα + and ERα- breast cancer, we performed a miRNA screening analysis in ERα + (MCF-7 and T47D) and ERα- (MDA-MB-231 and Hs578T) human breast cancer cell lines. The gene discussed is ESR1; the disease is breast carcinoma.